Dopamine Transporter Imaging With Single-Photon Emission Computed Tomography
ثبت نشده
چکیده
©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 16 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the “Company”), unless otherwise provided in the applicable contract. Medical technology is constantly evolving, and we reserve the right to review and update Medical Policy periodically.
منابع مشابه
6.01.54 Dopamine Transporter Imaging with Single -Photon Emission Computed Tomography
[TOP] Dopamine transporter imaging with single photon emission computed tomography (DAT-SPECT) is investigational for all indications, including but not limited to: Aiding in the diagnosis of patients with clinically uncertain parkinsonian syndromes; OR Distinguishing between parkinsonian syndromes and essential tremor; OR Distinguishing between dementia with Lewy bodies and Alzheimer dis...
متن کامل6.01.54 Dopamine Transporter Imaging with Single -Photon Emission Computed Tomography
[TOP] Dopamine transporter imaging with single photon emission computed tomography (DAT-SPECT) is investigational for all indications, including but not limited to: Aiding in the diagnosis of patients with clinically uncertain parkinsonian syndromes; OR Distinguishing between parkinsonian syndromes and essential tremor; OR Distinguishing between dementia with Lewy bodies and Alzheimer dis...
متن کامل6.01.54 Dopamine Transporter Imaging with Single -Photon Emission Computed Tomography
[TOP] Dopamine transporter imaging with single photon emission computed tomography (DAT-SPECT) is investigational for all indications, including but not limited to: Aiding in the diagnosis of patients with clinically uncertain parkinsonian syndromes; OR Distinguishing between parkinsonian syndromes and essential tremor; OR Distinguishing between dementia with Lewy bodies and Alzheimer dis...
متن کامل6.01.54 Dopamine Transporter Imaging with Single -Photon Emission Computed Tomography
[TOP] Dopamine transporter imaging with single photon emission computed tomography (DAT-SPECT) is investigational for all indications, including but not limited to: Aiding in the diagnosis of patients with clinically uncertain parkinsonian syndromes; OR Distinguishing between parkinsonian syndromes and essential tremor; OR Distinguishing between dementia with Lewy bodies and Alzheimer dis...
متن کاملCase Reports Dopamine Transporter Imaging in Psychogenic Parkinsonism and Neurodegenerative Parkinsonism with Psychogenic Overlay: A Report of Three Cases
Background: Differentiating psychogenic parkinsonism from neurodegenerative Parkinson’s disease (PD) with psychogenic features is a diagnostic challenge. Case report: We report a detailed longitudinal clinical description of three cases presenting with suspected psychogenic parkinsonism. Dopamine transporter single-photon emission computed tomography (DAT-SPECT) was used as a supplemental diagn...
متن کاملImprovement of diagnostic accuracy of Parkinson's disease on I-123-ioflupane single photon emission computed tomography (123I FP-CIT SPECT) using new Japanese normal database
Objective(s): I-123-ioflupane single photon emission computed tomography (FP-CIT-SPECT) has been used to assess dopamine transporter (DAT) loss in Parkinson's disease. The specific binding ratio (SBR), a quantitative parameter of DAT density in the striatum, may be affected by differences in age, sex, and SPECT system. The purpose of this study was to evaluate the util...
متن کامل